Search Within

Heiko Schoder

  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (72)
  3. Research Letter (4)
  4. Review (1)
Groups
  1. Department of Medicine (153)
  2. Hematologic Malignancies, Division of (153)
  3. Molecular Imaging and Therapy Service (153)
  4. Radiology, Department of (153)
  5. Center for Hematologic Malignancies (135)
  6. Lymphoma (128)

More Groups

People
  1. Andrew Zelenetz (66)
  2. Alison Moskowitz (59)
  3. David Straus (56)
  4. Ariela Noy (55)
  5. Maria Palomba (53)
  6. Paul Hamlin (51)

More People

Years
  1. 2025 (6)
  2. 2024 (13)
  3. 2023 (18)
  4. 2022 (7)
  5. 2021 (11)
  6. 2020 (10)

More Years

Publications
  1. Blood (49)
  2. Journal of Clinical Oncology (21)
  3. Hematological Oncology (11)
  4. Blood Advances (6)
  5. Journal of Nuclear Medicine (6)
  6. European Journal of Nuclear Medicine and Molecular Imaging (5)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. American Society of Clinical Oncology (21)
  3. Wiley Blackwell (14)
  4. Springer (8)
  5. Elsevier Inc. (6)
  6. Nature Publishing Group (6)

More Publishers

Results (153)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluating 18F-16 beta-fluoro-5 alpha-dihydrotestosterone (FDHT) and FDG PET as prognostic biomarkers for patients (pts) treated with abiraterone acetate (AA)
    Meeting Abstract

    Feldman, J. L.; Fox, J. J.; Autio, K. A.; Gavane, S. C.; Heller, G.; Schoder, H.; Humm, J.; Martinez, D. F.; Slovin, S. F.; Scher, H. I.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate-specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Sadelain, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Chimeric antigen receptor (CAR(+)) modified T cells targeting prostate specific membrane antigen (PSMA) in patients (pts) with castrate metastatic prostate cancer (CMPC)
    Meeting Abstract

    Slovin, S. F.; Wang, X.; Hullings, M.; Arauz, G.; Bartido, S.; Lewis, J. S.; Schoder, H.; Zanzonico, P.; Scher, H. I.; Riviere, I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in locally advanced gastroesophageal junction and gastric adenocarcinoma
    Meeting Abstract

    Ku, G. Y.; Kelsen, D. P.; Strong, V. E.; Schöder, H.; Janjigian, Y. Y.; Shah, M. A.; Coit, D. G.; Brennan, M. F.; Capanu, M.; Ilson, D. H.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • FDG-PET adapted sequential therapy with brentuximab vedotin and augmented ICE followed by autologous stem cell transplant for relapsed and refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Schoder, H.; Gerecitano, J. F.; Hamlin, P.; Horwitz, S. M.; Matasar, M. J.; Keskinyan, V. S.; McCall, S.; Noy, A.; Palomba, M. L.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma
    Journal Article

    Burger, I. A.; Vargas, H. A.; Goldman, D. A.; Gonen, M.; Kumar, A.; Zelenetz, A. D.; Schöder, H.; Hricak, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2013)

    Fulltext@MSK | Save
  • 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma
    Journal Article

    Casulo, C.; Schoder, H.; Feeney, J.; Lim, R.; Maragulia, J.; Zelenetz, A. D.; Horwitz, S.
    Leukemia and Lymphoma (2013)

    Fulltext@MSK | Save
  • ABVD alone and a PET scan complete remission negates the need for radiologic surveillance in early-stage, nonbulky Hodgkin lymphoma
    Journal Article

    Hartridge-Lambert, S. K.; Schoder, H.; Lim, R. C.; Maragulia, J. C.; Portlock, C. S.
    Cancer (2013)

    Fulltext@MSK | Save
  • Evaluation of dual tracer (FLT and FDG) PET imaging as part of risk-adapted therapy for patients with advanced stage diffuse large B cell lymphoma (DLBCL)
    Meeting Abstract

    Moskowitz, C. H.; Schoder, H.; Hamlin, P.; Maragulia, J. C.; Walkley, J.; Zelenetz, A. D.
    Blood (2012)

    Fulltext@MSK | Save